The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels-Reference-Cited by-同舟云学术

The differential sensitivity of Bc1-2-overexpressing human breast tumor cells to TRAIL or doxorubicin-induced apoptosis is dependent on Bc1-2 protein levels

Published:2001-10 Issue:48 Volume:20 Page:7128-7133
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

de Almodóvar Carmen Ruiz,Ruiz-Ruiz Carmen,Muñoz-Pinedo Cristina,Robledo Gema,López-Rivas Abelardo

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1204887.pdf

Reference44 articles.

1. Ashkenazi A, Dixit VM . 1999 Curr. Opin. Cell Biol. 11: 225–260

2. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH . 1999 J. Clin. Invest. 104: 155–162

3. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J . 2000 Nat. Cell Biol. 2: 241–243

4. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L . 1997 Immunity 7: 821–830

5. Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG . 1997a Immunity 7: 813–820

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms;Current Molecular Pharmacology;2024-02-16

2. Application of Dual-Drug Loaded Metal Organic Framework Nanomaterials Targeting PI3K Signaling Pathway in Triple Negative Breast Cancer Cells;Journal of Biomedical Nanotechnology;2022-10-01

3. Baicalin Enhances Chemosensitivity to Doxorubicin in Breast Cancer Cells via Upregulation of Oxidative Stress-Mediated Mitochondria-Dependent Apoptosis;Antioxidants;2021-09-23

4. Improvement in the Anti-Tumor Efficacy of Doxorubicin Nanosponges in In Vitro and in Mice Bearing Breast Tumor Models;Cancers;2020-01-09

5. Natural Product Modulators to Overcome Multidrug Resistance In Cancer;Nutrition and Cancer;2015-02-03